-
December 7: The Week in Cancer News
A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.
by Kate Yandell
-
November 30: The Week in Cancer News
A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.
by Kate Yandell
-
November 16: The Week in Cancer News
A study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.
by Bradley Jones
-
November 9: The Week in Cancer News
A study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.
by Kate Yandell
-
November 2: The Week in Cancer News
A survey shows that 39 percent of Americans believe that alternative therapies can cure cancer, and a trial finds that minimally invasive surgery is inferior to traditional surgery for treating cervical cancer.
by Kate Yandell
-
October 26: The Week in Cancer News
Researchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.
by Kate Yandell
-
October 19: The Week in Cancer News
A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
by Kate Yandell
-
October 12: The Week in Cancer News
A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
-
October 5: The Week in Cancer News
Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
by Kate Yandell
-
September 28: The Week in Cancer News
A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
Cancer Talk
Designing Clinical Trials for the Patient
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose